Diamines Derived Transition Metal Complexes of Naproxen: Synthesis, Characterization and Urease Inhibition Studies

Document Type : Research Article


1 Department of Chemistry, University of Sargodha, Sargodha 40100, PAKISTAN

2 Department of Physics, University of Sargodha, Sargodha 40100, PAKISTAN


A series of diamines derived transition metal complexes of naproxen with Zn(II), Cu(II), Ni(II), Co(II), Mn(II) have been synthesized and characterized by (FT)-IR, UV-Vis, NMR spectroscopy, magnetic susceptibility, and elemental analysis. Octahedral geometry has been proposed for all synthesized complexes based on magnetic susceptibility and electronic spectra. The crystal structures of Cu(II) complex with 1,2-diaminoethane (4b) is reported in this article. Structural studies provide the confirmation for the formation of Cu(H2O)2 (C2H8N2)2(np)2, which consists of two ionic naproxen moieties with different OMe orientation having intermolecular hydrogen bonding in solid-state. Jack bean Urease study of synthesized metal complexes was conducted and found that Cu and Ni complexes are more active having lower IC50 values against urease enzyme as compared to Zn, Co, and Mn complexes. Furthermore, urease inhibition studies showed that 1,2 diaminoethane and 1,3 diaminopropane derived transition metal complexes of naproxen (4a-e) and (5a-e), respectively have more inhibition efficacy as compared to simple metal naproxen complexes (3a-e). Amongst all, the synthesized complexes 4b and 4c have shown significant inhibition activities with IC50 values of 17.06 ± 0.05 and 18.07 ± 0.17 µM respectively, as compared to the standard drug thiourea.


Main Subjects

[1] Karplus P.A., Pearson M.A., Hausinger R.P., 70 Years of Crystalline Urease: What Have We Learned? Accounts of Chemical Research, 30(8): 330-337 (1997).
[2] Mobley H., Island M.D., Hausinger R.P., Molecular Biology of Microbial Ureases, Microbiol Rev., 59(3): 451-480 (1995).
[3] Gripenberg-Lerche C., Zhang L., Ahtonen P., Toivanen P., Skurnik M., Construction of Urease-Negative Mutants of Yersinia Enterocolitica Serotypes O: 3 and O: 8: Role of Urease in Virulence and Arthritogenicity, Infection And Immunity, 68(2): 942-947 (2000).
[4] Li X., Mobley H.L., Vaccines for Proteus Mirabilis in Urinary Tract Infection, International Journal
of Antimicrobial Agents
,19(6): 461-465 (2002).
[5] Algood H.M.S., Cover T.L., Helicobacter Pylori Persistence: an Overview of Interactions between
H. Pylori and Host Immune Defenses
, Clin Microbiol Rev., 19(4): 597-613 (2006).
[6] Tanaka T., Kawase M., Tani S., Α-Hydroxyketones as Inhibitors of Urease, Bioorg. Med. Chem., 12(2): 501-505 (2004).
[7] Shaw W.H., Raval D.N., The Inhibition of Urease by Metal Ions At Ph 8.9, J. Am. Chem. Soc., 83(15): 3184-3187( 1961).
[8] Upadhyay L.S.B., Urease Inhibitors: A Review, Indian J. Biotech., 11: 381-388 (2012).
[9] C. Follmer, Ureases as a Target for the Treatment of Gastric and Urinary Infections, J. Clin. Pathol., 63(5): 424-430 (2010).
[11] Rabia M., Mohamad A., Ismail N., Mahmoud A., Synthesis And Physico-Chemical Properties Of Some Ni (II) Complexes With Isatin-Hydrazones, Russian Journal of General Chemistry, 83(12): 2502-2509 (2013).
       DOI: 10.1134/S1070363213120487
[13] Chen W., Li Y., Cui Y., Zhang X., Zhu H-L., Zeng Q., Synthesis, Molecular Docking and Biological Evaluation of Schiff-Base Transition Metal Complexes as Potential Urease Inhibitors, Eur. J. Med. Chem., 45(10): 4473-4478 (2010).
[14] Pan L., Wang C., Yan K., Zhao K., Sheng G., Zhu H., Zhao X., Qu D., Niu F., You Z.,  Synthesis, Structures and Helicobacter Pylori Urease Inhibitory Activity of Copper (II) Complexes with Tridentate Aroylhydrazone Ligands, J. Inorg. Biochem., 159: 22-28(2016).
        Doi: 10.1016/J.Jinorgbio.2016.02.017.
[15] Jing C., Wang C., Yan K., Zhao K., Sheng G., Qu D., Et Al., Synthesis, Structures and Urease Inhibitory Activity of Cobalt (III) Complexes with Schiff Bases, Bioorg Med Chem., 24(2): 270-276 (2016).
[16] Rauf M.K., Yaseen S., Badshah A., Zaib S., Arshad R., Tahir M.N., Iqbal J., Synthesis, Characterization and Urease Inhibition, in Vitro Anticancer and Antileishmanial Studies of Ni (II) Complexes with N, N, N′-Trisubstituted Thioureas, J. Biol. Inorg. Chem., 20(3): 541-554 (2015).
        Doi: 10.1007/S00775-015-1239-5
[17] Hanif M., Nawaz M.A.H., Babak M.V., Iqbal J., Roller A., Keppler B.K., Hartinger C.G., Rutheniumii (Η6-Arene) Complexes of Thiourea Derivatives: Synthesis, Characterization and Urease Inhibition, Molecules, 19(6): 8080-8092 (2014).
        DOI: 10.3390/Molecules19068080
[18] Sorenson J.R., Oberley L.W., Kishore V., Leuthauser S.W., Oberley T.D., Pezeshk A., Copper Complexes: A Physiologic Approach to the Treatment of ‘Inflammatory Diseases’, Inorganica Chimica Acta, 79: 45-46 (1983).
[20] Patiño‐Camacho S.I., Moreno M.G.L., Flores‐Murrieta F.J., Déciga‐Campos M., The Pharmacokinetic Profile of the Combination of Naproxen and Tizanidine In Rat, Drug Development Research, 74(1): 31-37 (2013).
[21] Sheldrick G.M., A Short History of SHELX, Acta Crystallographica Section A, 64(1): 112-122 (2008)
[22] Siemens S., SAINT, Area-Detector Control and Integration Software, Siemens Analytical X-Ray Instruments Inc., Madison, WI, USA.(1995)
[23] Creno R.J., Wenk R.E., Bohlig P.. Automated Micromeasurement of Urea Using Urease and the Berthelot Reaction, Am. J. Clin. Pathol., 54(6): 828-832 (1970).